Opvee, High-Profile Overdose Antidote No One Used, Discontinues Marketing
Indivior PLC has discontinued marketing for Opvee, the opioid-overdose reversal product that the pharmaceutical ...
In-Hospital Drug-Use Study Shows Lived Experience Key to Better Policies
Patients using nonprescribed drugs in the hospital is a common issue, and raises dilemmas. ...
National Guard Sent to “Fight” Gangs in Memphis—But Gangs Run Tennessee’s Prisons
Any moment now, an unknown number of Tennessee National Guard troops are expected to ...
Poppy Growing Shifts to Pakistan After Taliban’s Crackdown in Afghanistan
Afghanistan used to have the distinction of producing the opium for 95 per cent ...
DOJ Seeks to Extend Stay, Delaying Cannabis Rescheduling by Months
A document viewed by Filter indicates that the Department of Justice will formally request ...
WHO’s COP11 Will Threaten Tobacco Harm Reduction Behind Closed Doors
In November, COP11—the World Health Organization’s 11th Conference of the Parties to its Framework ...
WI May Expand “Good Samaritan” Law to 911 Calls for Sexual Assault
Wisconsin is considering a proposal to offer legal immunity from certain controlled substance charges ...
Alaska Campaign to Legalize Psychedelics Is Gathering Signatures
Alaska activists have officially launched a signature drive to place an initiative on the ...
The Sex Offender Registry Shouldn’t Mean We’re Unwelcome at Church
In the Bible Belt, there’s basically a church on every corner—especially here in Nashville. ...
Landmark Deals Drop New Injectable PrEP From $28,000 to $40—for Some
Lenacapavir, the new long-acting HIV prevention medication that hit the United States market with ...
